Skip to main content
. Author manuscript; available in PMC: 2014 Aug 25.
Published in final edited form as: Anal Chem. 2012 Feb 28;84(6):2761–2768. doi: 10.1021/ac2030893

Figure 2.

Figure 2

Four IVIG brands were analyzed on a sialoglycan microarray19 (as described in methods at 0.5 mg/mL and 1 mg/mL). A. Representative binding reactivity against Neu5Gc-glycans epitopes at 1 mg/mL. B. IVIG-C binds specifically to Neu5Gc-glycans epitopes and not to Neu5Ac-glycans epitopes (P<0.0001; One-Way-ANOVA with Bonferroni’s multiple comparison test) with linear binding at 0.5 mg/mL and 1 mg/mL (P<0.0001; Pearson r=0.93 for correlation test).